Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
0.101
+0.003 (2.74%)
At close: Nov 4, 2024, 4:00 PM
4.770
+4.669 (4,618.10%)
Pre-market: Nov 5, 2024, 9:12 AM EST
Qualigen Therapeutics Employees
Qualigen Therapeutics had 4 employees as of December 31, 2023. The number of employees decreased by 34 or -89.47% compared to the previous year.
Employees
4
Change (1Y)
-34
Growth (1Y)
-89.47%
Revenue / Employee
n/a
Profits / Employee
-$2,444,028
Market Cap
54.64K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4 | -34 | -89.47% |
| Dec 31, 2022 | 38 | -8 | -17.39% |
| Dec 31, 2021 | 46 | 8 | 21.05% |
| Dec 31, 2020 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Xylo Technologies | 84 |
| Scorpius Holdings | 84 |
| Molecular Templates | 62 |
| Matinas BioPharma Holdings | 32 |
| HeartSciences | 15 |
| Sonnet BioTherapeutics Holdings | 12 |
| Phio Pharmaceuticals | 9 |
| GRI Bio | 4 |
QLGN News
- 4 days ago - Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024 - GlobeNewsWire
- 5 weeks ago - Qualigen Therapeutics, Inc. Announces management changes. - GlobeNewsWire
- 6 weeks ago - Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel - GlobeNewsWire
- 2 months ago - Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - GlobeNewsWire
- 2 months ago - Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering - GlobeNewsWire
- 2 months ago - Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering - GlobeNewsWire
- 5 months ago - Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination - GlobeNewsWire
- 7 months ago - Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting - GlobeNewsWire